CEUFAST COURSE

Placental Complications

Contact Hour(s): 1.5 Contact Hours Author: Kelly LaMonica (DNP(c), MSN, RNC-OB, EFM) This peer-reviewed course is applicable for the following professions: Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nu...

Course Summary

Contact Hour(s):  

1.5 Contact Hours 

Author: 

Kelly LaMonica (DNP(c), MSN, RNC-OB, EFM) 

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner 

Accreditations:  

The American Nurses Credentialing Center (ANCC)

State Approvals:  

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description: 

This course discusses the role of the placenta, the risk factors associated with abnormal placental development, the specific placental abnormalities and complications that can occur, what these complications might mean for a woman and her fetus, and the nursing care for a woman with placental complications. 

Outcomes: 

≥ 92% of participants will know how to care for patients with placental complications. 

Objectives:

After completing this continuing education course, the participant will be able to: 

  1. Define the role of the placenta.
  2. List the risk factors for an abnormal placenta.
  3. Describe the potential placental complications that can occur.
  4. Identify the risks to the mother and fetus that can occur as a result of placental complications.
  5. Plan the nursing care for women with placental complications. 

Disclosures: 

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.